• Instagram did not return a 200.
Katherin Patsch, PhD
Project Manager, Drug Discovery

310 228 6400 | kpatsch@eitm.org

Katherin Patsch, PhD, is a Project Manager, Drug Discovery at the Ellison Institute. As part of Dr. Mumenthaler’s team, she is working to design and implement an institute-wide drug discovery pipeline that supports innovative early discovery all the way to a portfolio of preclinical candidates. She coordinates with faculty and across functional teams to develop project plans that align short-term project tactics with long-term strategic goals.

Dr. Patsch received her PhD in Molecular and Cell Biology from the Medical University of Innsbruck in Tyrol, Austria, where she studied cell signaling in regenerating muscle. In 2012, she joined the Ellison Institute as a Postdoc to study androgen receptor dynamics in prostate cancer. As a Staff Scientist, she used her AR functional assays to test potential AR-targeting agents, which helped launch the Institute’s first drug discovery project.
Katherin Patsch, PhD
Project Manager, Drug Discovery

310 228 6400 | kpatsch@eitm.org

Katherin Patsch, PhD, is a Project Manager, Drug Discovery at the Ellison Institute. As part of Dr. Mumenthaler’s team, she is working to design and implement an institute-wide drug discovery pipeline that supports innovative early discovery all the way to a portfolio of preclinical candidates. She coordinates with faculty and across functional teams to develop project plans that align short-term project tactics with long-term strategic goals.

Dr. Patsch received her PhD in Molecular and Cell Biology from the Medical University of Innsbruck in Tyrol, Austria, where she studied cell signaling in regenerating muscle. In 2012, she joined the Ellison Institute as a Postdoc to study androgen receptor dynamics in prostate cancer. As a Staff Scientist, she used her AR functional assays to test potential AR-targeting agents, which helped launch the Institute’s first drug discovery project.